A survey of promoter binding sequences disclosed that all genes in the amplicon possess several putative binding sequences in their promoters for ERα, ERβ and the transcription factor E2F1 which is a target of activation by the cyclin D/CDK4 cascade in breast cancer with high proliferation fraction (Table 6). The gene discussed is ESR2; the disease is breast carcinoma.